ArticleInfectious diseases and therapy2014

In Vitro Assessment of Re-treatment Options for Patients with Hepatitis C Virus Genotype 1b Infection Resistant to Daclatasvir Plus Asunaprevir.

Jacques Friborg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.